The global antinuclear antibody test market is projected to grow at a CAGR of ~13% by attaining a noteworthy revenue during the forecast period, i.e., 2022 – 2031.
| Founded year: | Not set |
| Funding rounds: | Not set |
| Total funding amount: | Not set |
| Founded year: | Not set |
| Funding rounds: | Not set |
| Total funding amount: | Not set |